Opportunity Information: Apply for RFA HD 09 002
Apply for RFA HD 09 002
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Obstetric Pharmacology Research Units (U10)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Dec 16, 2008 and posted on Dec 16, 2008.
- Applicants must submit their applications by Mar 30, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $650,000.00 in funding.
- Eligible applicants include: Public housing authorities/Indian housing authorities Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Private institutions of higher education For profit organizations other than small businesses City or township governments County governments Others (see text field entitled Additional Information on Eligibility for clarification) State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Obstetric Pharmacology Research Units (OPRU) Network opportunity is a National Institutes of Health (NIH) cooperative agreement funded through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Its central goal is to build and sustain a coordinated research network that serves as a national resource for understanding how medications behave and work during pregnancy, including both normal and complicated pregnancies. The emphasis is on pharmacologic studies that clarify drug disposition (how a drug is absorbed, distributed, metabolized, and eliminated) and drug effects in pregnant patients, while also considering the fetus and placenta as key parts of the pregnancy pharmacology system.
Under this program, awardees would function as network units that carry out multi-site, cooperative clinical studies focused on therapies used during pregnancy. The work spans several connected areas: studying fetal, placental, and maternal pharmacology; examining how pregnancy alters drug-metabolizing enzymes, transporters, and other biologic effectors; and integrating pharmacogenetics and pharmacogenomics to understand how genetic variation may change medication response or safety in pregnant populations. The network is also designed to support translational research by facilitating the collection and use of clinical materials (for example, biologic samples and related clinical data) that can be leveraged for basic and mechanistic studies. A specific scientific priority is research on placental metabolism and the transfer of drugs across the placenta, which is essential for assessing fetal exposure and potential risks or benefits.
Beyond producing study results, the OPRU Network is structured to improve collaboration and information flow across disciplines. A stated objective is to enhance communication between basic scientists and obstetric clinicians, and to connect the wider set of specialists involved in caring for pregnant women, with the intent of accelerating interdisciplinary translational research. Another major component is workforce development: the network is expected to serve as a training resource for health professionals, including predoctoral and postdoctoral trainees and PharmD-level clinicians, with training topics centered on obstetric pharmacology, pharmacogenomics, and the design and conduct of clinical trials in pregnant women.
Administratively, this funding opportunity is a discretionary NIH program using a cooperative agreement mechanism (U10), which generally indicates substantial NIH programmatic involvement and coordination with awardees compared with a standard research grant. The funding opportunity number is RFA-HD-09-002, titled "Obstetric Pharmacology Research Units (U10)." The CFDA listing is 93.865 (Child Health and Human Development Extramural Research). The program listed an estimated total funding level of $5,000,000, with an award ceiling of $650,000, and no cost sharing or matching requirement. Key dates in the archived announcement include a posted date of December 16, 2008, and an original/current closing date of March 30, 2009, with an archive date of April 30, 2009.
Eligibility is broad and includes many types of organizations that can support clinical and translational research infrastructure. Eligible applicants include public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and various local and state government entities. The eligibility language also explicitly includes a range of mission-focused and community-centered institutions and organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, regional organizations, certain tribal governments and tribal organizations, and U.S. territories or possessions. The sponsoring agency is the NIH, with NICHD as the institute leading the program. The full announcement was linked through the NIH grants guide at the time of posting.
Obstetric Pharmacology Research Units (OPRU) Network (RFA-HD-09-002) FAQs
What is the OPRU Network funding opportunity?
The Obstetric Pharmacology Research Units (OPRU) Network opportunity is an NIH cooperative agreement intended to build and sustain a coordinated national research network focused on how medications behave and work during pregnancy. The network is designed to function as a national resource for understanding medication disposition and effects in pregnant patients, including normal and complicated pregnancies.
Which NIH institute leads this opportunity?
The opportunity is funded through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), within the National Institutes of Health (NIH).
What is the funding mechanism used for this program?
The program uses a cooperative agreement mechanism (U10). This generally indicates substantial NIH programmatic involvement and coordination with awardees compared with a standard research grant.
What is the Funding Opportunity Number and title?
The Funding Opportunity Number is RFA-HD-09-002. The title is "Obstetric Pharmacology Research Units (U10)."
What is the central scientific goal of the OPRU Network?
The central goal is to build and sustain a coordinated research network that advances understanding of how medications behave (pharmacokinetics and drug disposition) and how they work (drug effects) during pregnancy, while considering the fetus and placenta as key parts of the pregnancy pharmacology system.
What kinds of studies are emphasized?
The emphasis is on pharmacologic studies that clarify drug disposition (how a drug is absorbed, distributed, metabolized, and eliminated) and drug effects in pregnant patients, including both normal and complicated pregnancies.
Does the program consider the fetus and placenta in pharmacology studies?
Yes. The opportunity explicitly treats the fetus and placenta as key components of the pregnancy pharmacology system, and encourages research that helps assess fetal exposure and implications for risk or benefit.
What clinical research approach is expected from awardees?
Awardees would function as network units carrying out multi-site, cooperative clinical studies focused on therapies used during pregnancy.
What connected scientific areas does the network work span?
The program spans several connected areas, including fetal, placental, and maternal pharmacology; examination of how pregnancy alters drug-metabolizing enzymes, transporters, and other biologic effectors; and integration of pharmacogenetics and pharmacogenomics to understand how genetic variation may affect medication response or safety in pregnant populations.
Is pharmacogenetics or pharmacogenomics part of the program?
Yes. The network integrates pharmacogenetics and pharmacogenomics to evaluate how genetic variation may influence medication response or safety in pregnant populations.
Is there a translational research component?
Yes. The network is designed to support translational research by facilitating the collection and use of clinical materials (such as biologic samples and related clinical data) that can be leveraged for basic and mechanistic studies.
What is a specific scientific priority highlighted in the announcement?
A specific scientific priority is research on placental metabolism and the transfer of drugs across the placenta, which is essential for understanding fetal exposure and potential risks or benefits.
What collaboration and communication goals are stated for the network?
The network aims to improve collaboration and information flow across disciplines by enhancing communication between basic scientists and obstetric clinicians, and by connecting the broader set of specialists involved in caring for pregnant women to accelerate interdisciplinary translational research.
Is workforce development or training included in the network expectations?
Yes. The network is expected to serve as a training resource for health professionals, including predoctoral and postdoctoral trainees and PharmD-level clinicians.
What training topics are emphasized?
Training topics are centered on obstetric pharmacology, pharmacogenomics, and the design and conduct of clinical trials in pregnant women.
What is the CFDA listing associated with this opportunity?
The CFDA listing is 93.865, "Child Health and Human Development Extramural Research."
How much total funding was estimated for the program?
The program listed an estimated total funding level of $5,000,000.
What was the award ceiling?
The award ceiling was $650,000.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
When was the opportunity posted and when did it close?
Key dates in the archived announcement include a posted date of December 16, 2008, and an original/current closing date of March 30, 2009.
Is this funding opportunity archived?
Yes. The announcement includes an archive date of April 30, 2009.
What types of organizations are eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofits (including those with and without 501(c)(3) status); for-profit organizations (other than small businesses); small businesses; and various local and state government entities.
Are community-centered and mission-focused institutions explicitly included?
Yes. The eligibility language explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, and regional organizations.
Are tribal entities eligible?
Yes. The eligibility language includes certain tribal governments and tribal organizations.
Are U.S. territories or possessions included in eligibility?
Yes. The eligibility language includes U.S. territories or possessions.
Which agency sponsors the opportunity?
The sponsoring agency is the National Institutes of Health (NIH), with NICHD leading the program.
Where was the full announcement made available?
The full announcement was linked through the NIH grants guide at the time of posting.
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Youth Programs Academic Year Disability Components
Previous opportunity: Ancillary Studies in Immunomodulation Clinical Trials (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HD 09 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HD 09 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advanced Neural Prosthetics Research and Development (U01) Apply for PA 09 063 Funding Number: PA 09 063 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Enhancing Developmental Biology Research at Undergraduate Institutions Academic Research Enhancement Award (R15) Apply for PAR 09 084 Funding Number: PAR 09 084 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $150,000 |
| Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders SBIR (R43/R44) Apply for PA 07 396 Funding Number: PA 07 396 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Academic Community Partnership Conference Series (U13) Apply for PAR 09 092 Funding Number: PAR 09 092 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $30,000 |
| Childhood Obesity Prevention and Treatment Research Consortium (U01) Apply for RFA HL 10 004 Funding Number: RFA HL 10 004 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Childhood Obesity Prevention and Treatment Research Coordinating Unit (U01) Apply for RFA HL 10 005 Funding Number: RFA HL 10 005 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Outcomes Research in Orthotics and Prosthetics (R01) Apply for RFA HD 09 007 Funding Number: RFA HD 09 007 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $350,000 |
| Translational Research in Pediatric and Obstetric Pharmacology (R03) Apply for PAR 09 154 Funding Number: PAR 09 154 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Pediatric and Obstetric Pharmacology (R01) Apply for PAR 09 155 Funding Number: PAR 09 155 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Pediatric and Obstetric Pharmacology (R21) Apply for PAR 09 156 Funding Number: PAR 09 156 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $275,000 |
| Womens Reproductive Health Research (WRHR) Career Development Program (K12) Apply for RFA HD 09 026 Funding Number: RFA HD 09 026 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $440,000 |
| Considerations For The Safe and Effective Use of Iron Interventions In Context of Malaria and Its Co morbidities (U01) Apply for RFA HD 09 029 Funding Number: RFA HD 09 029 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Factors Affecting Cognitive Function in Adults with Down Syndrome (R01) Apply for RFA HD 09 028 Funding Number: RFA HD 09 028 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $500,000 |
| Noninvasive Assays of Human Oocytes and Preimplantation Embryos (STTR R41) Apply for RFA HD 09 024 Funding Number: RFA HD 09 024 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $100,000 |
| Noninvasive Assays of Human Oocytes and Preimplantation Embryos (SBIR R43) Apply for RFA HD 09 025 Funding Number: RFA HD 09 025 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $100,000 |
| Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54) Apply for RFA HD 09 027 Funding Number: RFA HD 09 027 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,000,000 |
| Safe and Effective Instruments and Devices for use in the Neonatal Intensive Care Units (STTR R41) Apply for RFA HD 09 018 Funding Number: RFA HD 09 018 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $225,000 |
| Advanced Tools and Technologies for Cerebrospinal Fluid Shunts STTR (R41/R42) Apply for PA 09 205 Funding Number: PA 09 205 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Advanced Tools and Technologies for Cerebrospinal Fluid Shunts SBIR (R43/R44) Apply for PA 09 206 Funding Number: PA 09 206 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Medical Rehabilitation Research Resource (R24) Apply for RFA HD 09 013 Funding Number: RFA HD 09 013 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 09 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.